22 recruiting, 10 not yet recruiting, 8 completed, 6 active not recruiting. 17 Not applicable, 4 Phase 2, 3 Phase 4, 2 Phase 1, 2 Phase 3.
Follow Chronic Kidney Disease(CKD): new trials by email Literature Review of Chronic Kidney Disease(CKD) trials Research Report on Chronic Kidney Disease(CKD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD) Endothelial cell collection - Obesity and Obesity-related Medical Conditions, Diabetes | Recruiting | Bettina Mittendorfer | 100 | 2027-01-01 | 2026-05-07 | |
| Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2) (IRIS-CKD Management Program): Education, (IRIS-CKD Management Program): GDMT - Chronic Kidney Disease(CKD), Type 2 DM | Not applicable | Recruiting | Duke University | 212 | 2025-10-28 | 2026-10-01 |
| Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD) (IRIS-CKD Screening Program): Home Kit, (IRIS-CKD Screening Program): Standard Lab Order - Chronic Kidney Disease(CKD), Type 2 DM | Not applicable | Recruiting | Duke University | 500 | 2025-10-28 | 2026-10-01 |
| Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens Metabolic Syndrome, Diabetes | Recruiting | Shanghai Changzheng Hospital | 4094 | 2025-07-01 | 2025-09-08 | |
| A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease Dapagliflozin, Semaglutide, Finerenone - Chronic Kidney Disease(CKD) | Phase 4 | Recruiting | Peter Rossing | 125 | 2025-06-20 | 2025-11-20 |
| Effect of Oral Health Educational Program on the Oral Health Related Quality of Life in a Group of Children with Chronic Kidney Disease Oral Health Educational Program - Chronic Kidney Disease(CKD) | Not applicable | Not yet recruiting | Cairo University | 30 | 2025-06-15 | 2025-03-17 |
| CKM Syndrome Prevalence and Its Association With SCORE-2 and BRI No intervention is applied. This is a non-interventional, observational study. Anthropometric measurements and existing laboratory data are used for CKM staging and risk assessment. - Metabolic Syndrome, Cardiovascular Diseases | Not yet recruiting | University of Gaziantep | 400 | 2025-06-01 | 2025-04-25 | |
| Predictors of Survival of DKD Patients in Assiut University Hospital Chronic Kidney Disease(CKD) | Not yet recruiting | Assiut University | 129 | 2025-05-01 | 2025-03-07 | |
| Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in Community No Intervention - Hyperkalemia, Chronic Kidney Disease(CKD) | Recruiting | Xiujuan Zang | 1890 | 2025-04-28 | 2025-07-11 | |
| Impact of Dapagliflozin in Anemic Chronic Kidney Disease Patients Dapagliflozin (DAPA), Erythropoiesis Stimulating Agent - Chronic Kidney Disease(CKD), Anemia, Kidney Disease, Chronic | Phase 2 | Recruiting | Mansoura University | 80 | 2025-04-01 | 2025-04-02 |
| Transcutaneous Laser Therapy in Chronic Kidney Disease Laser, Red Light - Chronic Kidney Disease(CKD) | Not applicable | Not yet recruiting | National Cheng-Kung University Hospital | 120 | 2025-03-17 | 2025-03-18 |
| An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease RESET-CKD, Attention Control - Chronic Kidney Disease(CKD) | Not applicable | Active not recruiting | University of Illinois at Chicago | 40 | 2025-03-13 | 2026-09-02 |
| Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome Spirulina Arthrospira platensis (microalgae), Gelidium corneum, Placebo - Stroke, Coronary Arterial Disease (CAD) | Not applicable | Recruiting | Universidade do Porto | 150 | 2025-03-11 | 2025-09-15 |
| A Study to Evaluate the Safety, Tolerability and PK of SK-08 SK-08, Placebo - Chronic Kidney Disease(CKD) | Phase 1 | Recruiting | Consun Pharmaceutical Group | 48 | 2025-03-09 | 2025-06-24 |
| Genomic First Testing in Chronic Kidney Disease Genetic Testing - Chronic Kidney Disease(CKD), Genetic Kidney Disease | Not yet recruiting | Dervla Connaughton | 2400 | 2025-03-01 | 2025-01-27 | |
| Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease Chronic Kidney Disease(CKD), Type 1 Diabetes (T1D) | Recruiting | The Cleveland Clinic | 60 | 2025-03-01 | 2026-07-08 | |
| Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0 Acute Kidney Injury, Fluid Overload | Enrolling by invitation | Indiana University | 8000 | 2025-03-01 | 2026-10-28 | |
| Acceptability and Feasibility of Interventions for Integrated Care of Chronic Kidney Disease With Other Long-term Health Conditions in Malawi: a Qualitative Study Receipt of healthcare for long-term conditions, Provision of healthcare, Policy making - Chronic Kidney Disease(CKD), Multimorbidity | Not yet recruiting | Liverpool School of Tropical Medicine | 60 | 2025-02-17 | 2025-02-04 | |
| Protecting Renal Function in Chronic Kidney Disease Patients with Isolated Nighttime Hypertension Antihypertensive treatment with Arotinolol or Amlodipine or Clonidine, Placebo-controlled group - Chronic Kidney Disease(CKD), Nocturnal Hypertension | Not applicable | Not yet recruiting | Shanghai Institute of Hypertension | 200 | 2025-01-30 | 2025-01-17 |
| The Effect of the Nutraceutical (-)- Epicatechin on Myosteatosis in Patients With Advanced CKD Epicatechin extract - Chronic Kidney Disease(CKD), Myosteatosis | Not applicable | Recruiting | Karolinska Institutet | 10 | 2025-01-17 | 2025-07-10 |
Showing 20 of 50. Sign in to see all of them.
Renal Insufficiency, Chronic (50) · Acute Kidney Injury (4) · Diabetes Mellitus (4) · Cardiovascular Diseases (3) · Diabetes Mellitus, Type 2 (3) · Dyslipidemias (3) · Hypertension (3) · Metabolic Syndrome (3) · Obesity (3) · Albuminuria (2) · Bone Diseases, Metabolic (2) · Cystic Fibrosis (2) · Heart Failure (2) · Hyperphosphatemia (2) · Insulin Resistance (2)
Chronic Disease (50) · Disease Attributes (50) · Female Urogenital Diseases (50) · Female Urogenital Diseases and Pregnancy Complications (50) · Male Urogenital Diseases (50) · Pathologic Processes (50) · Pathological Conditions, Signs and Symptoms (50) · Renal Insufficiency (50) · Urogenital Diseases (50) · Urologic Diseases (50) · Kidney Diseases (48) · Nutritional and Metabolic Diseases (16) · Metabolic Diseases (15) · Glucose Metabolism Disorders (9) · Endocrine System Diseases (8)
Sevelamer (2) · dapagliflozin (2) · finerenone (2) · Amiloride (1) · Amlodipine (1) · Antidepressive Agents (1) · Breathing Exercises (1) · Calcium Carbonate (1) · Catechin (1) · Clonidine (1) · Dietary Supplements (1) · Ferric Oxide, Saccharated (1) · Ferrosoferric Oxide (1) · Genetic Testing (1) · Hematinics (1)
Hacettepe University (3) · Duke University (2) · Indiana University (2) · Odense University Hospital (2) · AMAG Pharmaceuticals, Inc. (1) · Alebund Pharmaceuticals (1) · Angel Argiles (1) · Assistance Publique - Hôpitaux de Paris (1) · Assiut University (1) · Atlas University (1) · Bettina Mittendorfer (1) · Bo Feldt-Rasmussen (1) · Cairo University (1) · China National Center for Cardiovascular Diseases (1) · Consun Pharmaceutical Group (1)
United States (10) · China (9) · Turkey (Türkiye) (7) · Denmark (5) · France (4) · Canada (3) · Germany (3) · Spain (3) · United Kingdom (3) · Egypt (2) · Japan (2) · Mexico (2) · Portugal (2) · Sweden (2) · Argentina (1)
Neha Pagidipati, MD (2) · Angel Argiles (1) · Aydan Asli Aksel-Uylar (1) · Bettina Mittendorfer, PhD (1) · Bo Feldt-Rasmussen, Professor (1) · Bora Gulhan (1) · Cheng-Feng Lin Professor, PhD (1) · Chien-Yao Sun MD (1) · Claus Bistrup, MD, Professor (1) · Il Soo Ha, PhD (1) · Li-Chieh Kuo Professor, PhD (1) · Ligang Cui, Dr (1)
PMID 17276178, PMID 18765433, PMID 19414839, PMID 20048204, PMID 27012243, PMID 28372549, PMID 30675420, PMID 30802204, PMID 31222663, PMID 31326992, PMID 32223336, PMID 32232640, PMID 33020228, PMID 33306104, PMID 33394059, PMID 33914608, PMID 34032031, PMID 34453165, PMID 34462278, PMID 34660741, PMID 37598748, PMID 41618226, PMID 41928132, PMID 42113273, PMID 42155424, PMID 42426639, PMID 42448023, PMID 42754276
2023 (2), K12DK133995 (1), K23NR021034 (1), R21NR019348 (1)